Inactivation of Key Pathway Boosts the Body’s Immune Response Against Tumors

Aug. 6, 2025
Read time: <5 mins
Resize Image Project (25)

Could a new genetic approach make cancer therapies more effective? University of Michigan researchers are investigating how targeting the genes CDK12 and CDK13 can activate the STING signaling pathway, potentially boosting the body’s natural immune response and overcoming resistance to current treatments. Continue reading to learn more about this promising strategy.

Share:
We use cookies to ensure you get the best experience on our website. By using this site, you accept our use of cookies.